Works matching IS 0008543X AND DT 2012 AND VI 118 AND IP 1


Results: 48
    1
    2

    Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.

    Published in:
    2012
    By:
    • Nicolini FE;
    • Turkina A;
    • Shen ZX;
    • Gallagher N;
    • Jootar S;
    • Powell BL;
    • De Souza C;
    • Zheng M;
    • Szczudlo T;
    • le Coutre P;
    • Nicolini, Franck E;
    • Turkina, Anna;
    • Shen, Zhi-Xiang;
    • Gallagher, Neil;
    • Jootar, Saengsuree;
    • Powell, Bayard L;
    • De Souza, Carmino;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • le Coutre, Philipp
    Publication type:
    journal article
    3
    4
    5

    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.

    Published in:
    2012
    By:
    • Llombart-Cussac A;
    • Ruiz A;
    • Antón A;
    • Barnadas A;
    • Antolín S;
    • Alés-Martínez JE;
    • Alvarez I;
    • Andrés R;
    • García Saenz JA;
    • Lao J;
    • Carrasco E;
    • Cámara C;
    • Casas I;
    • Martín M;
    • Llombart-Cussac, Antonio;
    • Ruiz, Amparo;
    • Antón, Antonio;
    • Barnadas, Agustí;
    • Antolín, Silvia;
    • Alés-Martínez, José E
    Publication type:
    journal article
    7
    8
    10
    11
    12
    13
    14
    15

    Dasatinib combined with docetaxel for castration-resistant prostate cancer.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 63, doi. 10.1002/cncr.26204
    By:
    • Araujo, John C.;
    • Mathew, Paul;
    • Armstrong, Andrew J.;
    • Braud, Edward L.;
    • Posadas, Edwin;
    • Lonberg, Mathew;
    • Gallick, Gary E.;
    • Trudel, Géralyn C.;
    • Paliwal, Prashni;
    • Agrawal, Shruti;
    • Logothetis, Christopher J.
    Publication type:
    Article
    16
    17

    Conflict of interest in oncology publications.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 188, doi. 10.1002/cncr.26237
    By:
    • Kesselheim, Aaron S.;
    • Lee, Joy L.;
    • Avorn, Jerry;
    • Servi, Amber;
    • Shrank, William H.;
    • Choudhry, Niteesh K.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 268, doi. 10.1002/cncr.26243
    By:
    • Estrella, Jeannelyn S.;
    • Rashid, Asif;
    • Fleming, Jason B.;
    • Katz, Matthew H.;
    • Lee, Jeffrey E.;
    • Wolf, Robert A.;
    • Varadhachary, Gauri R.;
    • Pisters, Peter W. T.;
    • Abdalla, Eddie K.;
    • Vauthey, Jean-Nicolas;
    • Wang, Hua;
    • Gomez, Henry F.;
    • Evans, Douglas B.;
    • Abbruzzese, James L.;
    • Wang, Huamin
    Publication type:
    Article
    25

    Serum cell-free DNA in renal cell carcinoma.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 82, doi. 10.1002/cncr.26254
    By:
    • de Martino, Michela;
    • Klatte, Tobias;
    • Haitel, Andrea;
    • Marberger, Michael
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Expanding Nilotinib Access in Clinical Trials (ENACT).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 118, doi. 10.1002/cncr.26249
    By:
    • Nicolini, Franck E.;
    • Turkina, Anna;
    • Shen, Zhi-Xiang;
    • Gallagher, Neil;
    • Jootar, Saengsuree;
    • Powell, Bayard L.;
    • De Souza, Carmino;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • le Coutre, Philipp
    Publication type:
    Article